Cargando…

Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide

Interstitial lung disease (ILD) is a major cause of morbidity and mortality in scleroderma (systemic sclerosis, or SSc). Fibrocytes are a monocyte-derived cell population implicated in the pathogenesis of fibrosing disorders. Given the recently recognized importance of caveolin-1 in regulating funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Tourkina, Elena, Bonner, Michael, Oates, James, Hofbauer, Ann, Richard, Mathieu, Znoyko, Sergei, Visconti, Richard P, Zhang, Jing, Hatfield, Corey M, Silver, Richard M, Hoffman, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155832/
https://www.ncbi.nlm.nih.gov/pubmed/21722364
http://dx.doi.org/10.1186/1755-1536-4-15
_version_ 1782210155459379200
author Tourkina, Elena
Bonner, Michael
Oates, James
Hofbauer, Ann
Richard, Mathieu
Znoyko, Sergei
Visconti, Richard P
Zhang, Jing
Hatfield, Corey M
Silver, Richard M
Hoffman, Stanley
author_facet Tourkina, Elena
Bonner, Michael
Oates, James
Hofbauer, Ann
Richard, Mathieu
Znoyko, Sergei
Visconti, Richard P
Zhang, Jing
Hatfield, Corey M
Silver, Richard M
Hoffman, Stanley
author_sort Tourkina, Elena
collection PubMed
description Interstitial lung disease (ILD) is a major cause of morbidity and mortality in scleroderma (systemic sclerosis, or SSc). Fibrocytes are a monocyte-derived cell population implicated in the pathogenesis of fibrosing disorders. Given the recently recognized importance of caveolin-1 in regulating function and signaling in SSc monocytes, in the present study we examined the role of caveolin-1 in the migration and/or trafficking and phenotype of monocytes and fibrocytes in fibrotic lung disease in human patients and an animal model. These studies fill a gap in our understanding of how monocytes and fibrocytes contribute to SSc-ILD pathology. We found that C-X-C chemokine receptor type 4-positive (CXCR4(+))/collagen I-positive (ColI(+)), CD34(+)/ColI(+ )and CD45(+)/ColI(+ )cells are present in SSc-ILD lungs, but not in control lungs, with CXCR4(+ )cells being most prevalent. Expression of CXCR4 and its ligand, stromal cell-derived factor 1 (CXCL12), are also highly upregulated in SSc-ILD lung tissue. SSc monocytes, which lack caveolin-1 and therefore overexpress CXCR4, exhibit almost sevenfold increased migration toward CXCL12 compared to control monocytes. Restoration of caveolin-1 function by administering the caveolin scaffolding domain (CSD) peptide reverses this hypermigration. Similarly, transforming growth factor β-treated normal monocytes lose caveolin-1, overexpress CXCR4 and exhibit 15-fold increased monocyte migration that is CSD peptide-sensitive. SSc monocytes exhibit a different phenotype than normal monocytes, expressing high levels of ColI, CD14 and CD34. Because ColI(+)/CD14(+ )cells are prevalent in SSc blood, we looked for such cells in lung tissue and confirmed their presence in SSc-ILD lungs but not in normal lungs. Finally, in the bleomycin model of lung fibrosis, we show that CSD peptide diminishes fibrocyte accumulation in the lungs. Our results suggest that low caveolin-1 in SSc monocytes contributes to ILD via effects on cell migration and phenotype and that the hyperaccumulation of fibrocytes in SSc-ILD may result from the altered phenotype and migratory activity of their monocyte precursors.
format Online
Article
Text
id pubmed-3155832
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31558322011-08-15 Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide Tourkina, Elena Bonner, Michael Oates, James Hofbauer, Ann Richard, Mathieu Znoyko, Sergei Visconti, Richard P Zhang, Jing Hatfield, Corey M Silver, Richard M Hoffman, Stanley Fibrogenesis Tissue Repair Research Interstitial lung disease (ILD) is a major cause of morbidity and mortality in scleroderma (systemic sclerosis, or SSc). Fibrocytes are a monocyte-derived cell population implicated in the pathogenesis of fibrosing disorders. Given the recently recognized importance of caveolin-1 in regulating function and signaling in SSc monocytes, in the present study we examined the role of caveolin-1 in the migration and/or trafficking and phenotype of monocytes and fibrocytes in fibrotic lung disease in human patients and an animal model. These studies fill a gap in our understanding of how monocytes and fibrocytes contribute to SSc-ILD pathology. We found that C-X-C chemokine receptor type 4-positive (CXCR4(+))/collagen I-positive (ColI(+)), CD34(+)/ColI(+ )and CD45(+)/ColI(+ )cells are present in SSc-ILD lungs, but not in control lungs, with CXCR4(+ )cells being most prevalent. Expression of CXCR4 and its ligand, stromal cell-derived factor 1 (CXCL12), are also highly upregulated in SSc-ILD lung tissue. SSc monocytes, which lack caveolin-1 and therefore overexpress CXCR4, exhibit almost sevenfold increased migration toward CXCL12 compared to control monocytes. Restoration of caveolin-1 function by administering the caveolin scaffolding domain (CSD) peptide reverses this hypermigration. Similarly, transforming growth factor β-treated normal monocytes lose caveolin-1, overexpress CXCR4 and exhibit 15-fold increased monocyte migration that is CSD peptide-sensitive. SSc monocytes exhibit a different phenotype than normal monocytes, expressing high levels of ColI, CD14 and CD34. Because ColI(+)/CD14(+ )cells are prevalent in SSc blood, we looked for such cells in lung tissue and confirmed their presence in SSc-ILD lungs but not in normal lungs. Finally, in the bleomycin model of lung fibrosis, we show that CSD peptide diminishes fibrocyte accumulation in the lungs. Our results suggest that low caveolin-1 in SSc monocytes contributes to ILD via effects on cell migration and phenotype and that the hyperaccumulation of fibrocytes in SSc-ILD may result from the altered phenotype and migratory activity of their monocyte precursors. BioMed Central 2011-07-01 /pmc/articles/PMC3155832/ /pubmed/21722364 http://dx.doi.org/10.1186/1755-1536-4-15 Text en Copyright ©2011 Tourkina et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tourkina, Elena
Bonner, Michael
Oates, James
Hofbauer, Ann
Richard, Mathieu
Znoyko, Sergei
Visconti, Richard P
Zhang, Jing
Hatfield, Corey M
Silver, Richard M
Hoffman, Stanley
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
title Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
title_full Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
title_fullStr Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
title_full_unstemmed Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
title_short Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
title_sort altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155832/
https://www.ncbi.nlm.nih.gov/pubmed/21722364
http://dx.doi.org/10.1186/1755-1536-4-15
work_keys_str_mv AT tourkinaelena alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT bonnermichael alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT oatesjames alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT hofbauerann alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT richardmathieu alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT znoykosergei alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT viscontirichardp alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT zhangjing alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT hatfieldcoreym alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT silverrichardm alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide
AT hoffmanstanley alteredmonocyteandfibrocytephenotypeandfunctioninsclerodermainterstitiallungdiseasereversalbycaveolin1scaffoldingdomainpeptide